Skip to main content

Retail Clinics

  • California Rite Aid stores offer discounted whooping cough vaccinations

    CAMP HILL, Pa. — Rite Aid is selling whooping cough vaccines to parents in California at a reduced price, the retailer said Thursday.

    As of July 1, a new state law will require proof of vaccination for all students entering grades 7 through 12, and nearly all of the retail pharmacy chain’s 600 stores in California will be able to vaccinate walk-in patients or by appointment. The reduced-price vaccine will sell for $57.99.

  • ODH: 2009 H1N1 vaccines prevented deaths

    COLUMBUS, Ohio — An Ohio Department of Health study released Wednesday estimated that Ohio’s H1N1 vaccination efforts prevented 64 deaths, 1,400 hospitalizations and 310,402 cases of influenza during the 2009 H1N1 pandemic. The study also estimated that Ohio’s vaccination efforts saved the state $8.4 million in H1N1-related hospitalization costs.

  • Government agencies draft plan to curb opioid abuse

    WASHINGTON — The Obama administration is looking to curb the growing national epidemic of prescription painkiller abuse, according to a plan unveiled Tuesday.

    Elements of the plan include expansion of state-based prescription drug monitoring programs, recommendation of convenient and environmentally responsible drug-disposal methods, education and reduction of doctor shopping.

  • InhalerWear introduces pediatric asthma compliance tool

    BOSTON — InhalerWear on Tuesday announced its launch of a neoprene cover for inhalers that will help make carrying around an inhaler “trendy and cool” to children and teenagers. The new inhaler can be clipped to a backpack, purse or belt loop.

    "We started InhalerWear because we knew the challenge facing parents was not in getting their kids to use their inhaler, but to get them to carry their inhalers with them at all times,” stated co-founder Rob Fiore.

  • Study: Drug-drug interaction warning letters work

    ST. PAUL, Minn. — A letter educating healthcare providers regarding a drug-drug interaction between prescription anticlotting drug Plavix (clopidogrel) and a proton-pump inhibitor has resulted in a reduction in the number of patients combining the two therapies, according to a new study by Prime Therapeutics released Monday.

  • Deloitte: Consumers turn to various resources for recall information

    NEW YORK — Consumers that seek timely and detailed information about product recalls look to multiple resources, according to a new Deloitte survey.

  • CDC experts spotlighted in 'Killer Outbreaks'

    ATLANTA — The Centers for Disease Control and Prevention is participating in a new docudrama that debuts on Animal Planet beginning Friday at 9 p.m., the agency announced earlier this week.

    Animal Planet has ordered six episodes of the new series “Killer Outbreaks.” Each episode features potentially deadly viruses and includes commentary from CDC experts and victims of the outbreaks. "Killer Outbreaks" began production in March 2010, and in total, producers interviewed 43 subject matter experts from across the agency.

  • Takeda's Edarbi enters market

    DEERFIELD, Ill. — Takeda Pharmaceutical has launched a new treatment for high blood pressure, the company said Friday.

    Takeda announced the launch of Edarbi (azilsartan medoxomil), which the Food and Drug Administration approved on Feb. 25 as a once-daily pill for hypertension.

X
This ad will auto-close in 10 seconds